Allergan Income Statement
View: Annual | Quarterly
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Revenue | 1,172.0 | 1,076.6 | 1,090.6 | 973.7 | 988.1 |
| Cost of Goods Sold | 197.5 | 182.2 | 179.8 | 159.5 | 174.5 |
| Gross Profit | 974.5 | 894.4 | 910.8 | 814.2 | 813.6 |
| Gross Profit Margin | 83.1% | 83.1% | 83.5% | 83.6% | 82.3% |
| SG&A Expense | 699.9 | 663.9 | 632.2 | 536.2 | 578.3 |
| Depreciation & Amortization | 65.6 | 64.5 | 60.2 | 54.1 | 53.6 |
| Operating Income | 209.0 | 166.0 | 218.4 | 223.9 | 181.7 |
| Operating Margin | 17.8% | 15.4% | 20.0% | 23.0% | 18.4% |
| Nonoperating Income | 1.9 | 5.0 | 8.3 | 8.3 | 10.1 |
| Nonoperating Expenses | 14.8 | 15.4 | 17.9 | 17.5 | 17.5 |
| Income Before Taxes | 196.1 | 155.6 | 208.8 | 214.7 | 174.3 |
| Income Taxes | 48.4 | 44.0 | 47.5 | 56.5 | 36.0 |
| Net Income After Taxes | 147.7 | 111.6 | 161.3 | 158.2 | 138.3 |
| Continuing Operations | 147.3 | 111.4 | 161.2 | 158.2 | 137.8 |
| Discontinued Operations | -- | -- | (0.9) | (0.8) | -- |
| Total Operations | 147.3 | 111.4 | 160.3 | 157.4 | 137.8 |
| Total Net Income | 147.3 | 111.4 | 160.3 | 157.4 | 137.8 |
| Net Profit Margin | 12.6% | 10.3% | 14.7% | 16.2% | 13.9% |
| Diluted EPS from Total Net Income ($) | 0.48 | 0.36 | 0.52 | 0.51 | 0.45 |
| Dividends per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |





